264 related articles for article (PubMed ID: 27043317)
1. Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors.
Lv PC; Roy J; Putt KS; Low PS
Mol Pharm; 2016 May; 13(5):1618-25. PubMed ID: 27043317
[TBL] [Abstract][Full Text] [Related]
2. Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence Imaging of Hypoxic Tumors.
Mahalingam SM; Chu H; Liu X; Leamon CP; Low PS
Bioconjug Chem; 2018 Oct; 29(10):3320-3331. PubMed ID: 30185025
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia.
Bao B; Groves K; Zhang J; Handy E; Kennedy P; Cuneo G; Supuran CT; Yared W; Rajopadhye M; Peterson JD
PLoS One; 2012; 7(11):e50860. PubMed ID: 23226406
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a Centyrin-Based Near-Infrared Probe for Fluorescence-Guided Surgery of Epidermal Growth Factor Receptor Positive Tumors.
Mahalingam SM; Dudkin VY; Goldberg S; Klein D; Yi F; Singhal S; O'Neil KT; Low PS
Bioconjug Chem; 2017 Nov; 28(11):2865-2873. PubMed ID: 28945346
[TBL] [Abstract][Full Text] [Related]
6. Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages.
Alsaab HO; Sau S; Alzhrani RM; Cheriyan VT; Polin LA; Vaishampayan U; Rishi AK; Iyer AK
Biomaterials; 2018 Nov; 183():280-294. PubMed ID: 30179778
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors.
Groves K; Bao B; Zhang J; Handy E; Kennedy P; Cuneo G; Supuran CT; Yared W; Peterson JD; Rajopadhye M
Bioorg Med Chem Lett; 2012 Jan; 22(1):653-7. PubMed ID: 22079760
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.
van Brussel AS; Adams A; Vermeulen JF; Oliveira S; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM
Breast Cancer Res Treat; 2013 Jul; 140(2):263-72. PubMed ID: 23860929
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.
Lv PC; Putt KS; Low PS
Bioconjug Chem; 2016 Jul; 27(7):1762-9. PubMed ID: 27362480
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Nonpeptidic Ligand Conjugates for the Treatment of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.
Lv PC; Roy J; Putt KS; Low PS
Mol Cancer Ther; 2017 Mar; 16(3):453-460. PubMed ID: 27980101
[TBL] [Abstract][Full Text] [Related]
13. Quicker, deeper and stronger imaging: A review of tumor-targeted, near-infrared fluorescent dyes for fluorescence guided surgery in the preclinical and clinical stages.
Jiao J; Zhang J; Yang F; Song W; Han D; Wen W; Qin W
Eur J Pharm Biopharm; 2020 Jul; 152():123-143. PubMed ID: 32437752
[TBL] [Abstract][Full Text] [Related]
14. Acetazolamide-based [
More KN; Lee JY; Kim DY; Cho NC; Pyo A; Yun M; Kim HS; Kim H; Ko K; Park JH; Chang DJ
Bioorg Med Chem Lett; 2018 Mar; 28(5):915-921. PubMed ID: 29422388
[TBL] [Abstract][Full Text] [Related]
15. New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples.
Stravinskiene D; Imbrasaite A; Petrikaite V; Matulis D; Matuliene J; Zvirbliene A
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31349673
[TBL] [Abstract][Full Text] [Related]
16. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
[TBL] [Abstract][Full Text] [Related]
17. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.
Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F
J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302
[TBL] [Abstract][Full Text] [Related]
18. Carbonic Anhydrase IX Targeting Mn(II)-Based Magnetic Resonance Molecular Imaging Probe for Hypoxia Tumors.
Cao W; Yang J; Zhu C; Zeng Z; Yang C; Chen T; Zhu J
Bioconjug Chem; 2023 Jun; 34(6):1166-1175. PubMed ID: 37285478
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18 click radiosynthesis and microPET/CT evaluation of a small peptide-a potential PET probe for carbonic anhydrase IX.
Jia L; Li X; Cheng D; Zhang L
Bioorg Med Chem; 2019 Mar; 27(5):785-789. PubMed ID: 30683555
[TBL] [Abstract][Full Text] [Related]
20. A novel
Guan SS; Wu CT; Liao TZ; Lin KL; Peng CL; Shih YH; Weng MF; Chen CT; Yeh CH; Wang YC; Liu SH
Eur J Pharm Biopharm; 2021 Nov; 168():38-52. PubMed ID: 34450241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
